GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 142 filers reported holding GOSSAMER BIO INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $300,000 | -4.8% | 250,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $315,000 | -90.9% | 250,000 | -37.5% | 0.00% | -88.2% |
Q1 2022 | $3,472,000 | -23.3% | 400,000 | 0.0% | 0.03% | -19.0% |
Q4 2021 | $4,524,000 | -10.0% | 400,000 | 0.0% | 0.04% | -2.3% |
Q3 2021 | $5,028,000 | – | 400,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 6,953,416 | $154,227,000 | 39.34% |
Samsara BioCapital, LLC | 376,583 | $8,353,000 | 5.52% |
Boxer Capital, LLC | 1,875,000 | $41,588,000 | 3.58% |
Hillhouse Capital Management | 4,974,041 | $110,324,000 | 3.52% |
EcoR1 Capital, LLC | 772,096 | $17,125,000 | 1.73% |
Artal Group S.A. | 1,608,968 | $35,687,000 | 1.44% |
CLOUGH CAPITAL PARTNERS L P | 449,934 | $9,915,000 | 0.97% |
Cormorant Asset Management, LP | 643,129 | $14,265,000 | 0.82% |
HHLR ADVISORS, LTD. | 937,500 | $20,794,000 | 0.46% |
Nicholas Investment Partners, LP | 143,342 | $3,179,000 | 0.29% |